NDLI: Randomized trial of two schedules of low-dose gemtuzumab ozogamicin as induction monotherapy for newly diagnosed acute myeloid leukaemia in older patients not considered candidates for intensive chemotherapy. A phase II study of the EORTC and GIMEMA leukaemia groups (AML-19)

Content Provider	Scilit
Author	Amadori, Sergio Suciu, Stefan Selleslag, Dominik Stasi, Roberto Alimena, Giuliana Baila, Liliana Rizzoli, Vittorio Borlenghi, Erika Gaidano, Gianluca Magro, Domenico Torelli, Giuseppe Muus, Petra Venditti, Adriano Cacciola, Emma Lauria, Francesco Vignetti, Marco Witte, Theo De
Copyright Year	2010
Description	Journal: British Journal of Haematology
Related Links	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2864316/pdf
Ending Page	382
Page Count	7
Starting Page	376
e-ISSN	13652141
DOI	10.1111/j.1365-2141.2010.08095.x
Journal	British Journal of Haematology
Issue Number	3
Volume Number	149
Language	English
Publisher	Wiley-Blackwell
Publisher Date	2010-04-12
Access Restriction	Open
Subject Keyword	Journal: British Journal of Haematology Acute Myeloid Leukaemia Gemtuzumab Ozogamicin Targeted Therapy Supportive Care
Content Type	Text
Resource Type	Article

Central Library (ISO-9001:2015 Certified)
Indian Institute of Technology Kharagpur
Kharagpur, West Bengal, India | PIN - 721302

See location in the Map
03222 282435
Mail: support@ndl.gov.in

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Randomized trial of two schedules of low-dose gemtuzumab ozogamicin as induction monotherapy for newly diagnosed acute myeloid leukaemia in older patients not considered candidates for intensive chemotherapy. A phase II study of the EORTC and GIMEMA leukaemia groups (AML-19)